Anavex Life Sciences (AVXL) EPS (Basic) (2016 - 2025)
Anavex Life Sciences (AVXL) reported EPS (Basic) of -$28.7 for Q4 2025, down 2843.41% on a YoY basis from $1.05 in Q4 2024, and up 93.84% sequentially from -$465.78 in Q3 2025.
Anavex Life Sciences (AVXL) EPS (Basic) (2016 - 2025) Analysis & Trends
Anavex Life Sciences (AVXL) has 10 years of EPS (Basic) data on file, last reported at -$28.7 in Q4 2025.
- For the quarter ending Q4 2025, EPS (Basic) fell 2843.41% year-over-year to -$28.7; the trailing twelve-month figure through Dec 2025 stood at -$476.17 (down 34354.77% YoY), and the FY2025 full-year result was -$466.26, down 90402.24% from the prior year.
- EPS (Basic) climbed to -$28.7 in Q4 2025, from -$465.78 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.11 in Q4 2023 to a low of -$465.78 in Q3 2025.
- A 5-year average of -$24.95 and a median of -$0.15 in 2022 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) surged 36.85% in 2023 and tumbled 330946.27% in 2025, its largest moves.
- Tracing AVXL's EPS (Basic) over 5 years: stood at -$0.14 in 2021, then decreased by 16.18% to -$0.17 in 2022, then jumped by 36.85% to -$0.11 in 2023, then sank by 828.31% to -$0.98 in 2024, then tumbled by 2843.41% to -$28.7 in 2025.
- Business Quant data shows AVXL's EPS (Basic) at -$28.7 in Q4 2025, -$465.78 in Q3 2025, and -$0.71 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Anavex Life Sciences | 214.12 Mn | 82.37 Mn | - | -28.70 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -28.70 |
| Sep 30, 2025 | -465.78 |
| Jun 30, 2025 | -0.71 |
| Mar 31, 2025 | -0.60 |
| Dec 31, 2024 | -0.98 |
| Sep 30, 2024 | -0.14 |
| Jun 30, 2024 | -0.14 |
| Mar 31, 2024 | -0.13 |
| Dec 31, 2023 | -0.11 |
| Sep 30, 2023 | -0.13 |
| Jun 30, 2023 | -0.14 |
| Mar 31, 2023 | -0.17 |
| Dec 31, 2022 | -0.17 |
| Sep 30, 2022 | -0.19 |
| Jun 30, 2022 | -0.16 |
| Mar 31, 2022 | -0.14 |
| Dec 31, 2021 | -0.14 |
| Sep 30, 2021 | -0.17 |
| Jun 30, 2021 | -0.14 |
| Mar 31, 2021 | -0.12 |